mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |